FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2927351594> ?p ?o ?g. }

• W2927351594 abstract "INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicity and route of administration of standard drugs. Miltefosine is an oral agent used for leishmaniasis treatment; however, no data exist regarding its use for ML in Brazil. In this study, we aimed to evaluate the efficacy of miltefosine for ML treatment compared to that of pentavalent antimonial in a pilot study. METHODS: We performed a randomized clinical trial with two parallel groups. The tested intervention consisted of miltefosine 1.3-2 mg/kg/day (two capsules) for 28 days or intravenous 20 mg SbV/kg/day of meglumine antimoniate (N-MA) for 30 days. The final endpoint was defined as complete healing of the lesion four years after treatment. We also analyzed an early endpoint at 90 days after treatment. RESULTS: Forty patients were included in this study: each experimental group comprised 20 patients. Applying a multivariate model in an intention-to-treat analysis, we observed that patients treated with miltefosine had a cure probability 2.08 times greater (95% confidence interval [CI] = 1.03-4.18) than those treated with N-MA at 90 days after treatment. At the final endpoint, we observed no differences in cure probability between miltefosine and N-MA (relative risk = 0.66; 95% CI = 0.33-1.32). With respect to adverse reactions, significant differences between groups were related to gastrointestinal effects, which were more frequent in the miltefosine group. CONCLUSIONS: Miltefosine may be an interesting alternative for treating ML because of its oral administration and cure rate after long-term follow-up." @default.
• W2927351594 created "2019-04-11" @default.
• W2927351594 creator A5006447860 @default.
• W2927351594 creator A5012747514 @default.
• W2927351594 creator A5013224966 @default.
• W2927351594 creator A5022215664 @default.
• W2927351594 creator A5029601316 @default.
• W2927351594 creator A5032927791 @default.
• W2927351594 creator A5053182124 @default.
• W2927351594 creator A5057647506 @default.
• W2927351594 creator A5065033497 @default.
• W2927351594 creator A5070849509 @default.
• W2927351594 date "2019-01-01" @default.
• W2927351594 modified "2023-10-02" @default.
• W2927351594 title "A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis" @default.
• W2927351594 cites W1592307690 @default.
• W2927351594 cites W1831164048 @default.
• W2927351594 cites W1891303481 @default.
• W2927351594 cites W1957126776 @default.
• W2927351594 cites W1963542761 @default.
• W2927351594 cites W1963947842 @default.
• W2927351594 cites W1972833535 @default.
• W2927351594 cites W1975590813 @default.
• W2927351594 cites W1976174823 @default.
• W2927351594 cites W1980415430 @default.
• W2927351594 cites W1991702319 @default.
• W2927351594 cites W1995191885 @default.
• W2927351594 cites W2004277731 @default.
• W2927351594 cites W2006411452 @default.
• W2927351594 cites W2007467973 @default.
• W2927351594 cites W2023608549 @default.
• W2927351594 cites W2031115115 @default.
• W2927351594 cites W2038206223 @default.
• W2927351594 cites W2041065394 @default.
• W2927351594 cites W2050197274 @default.
• W2927351594 cites W2052645253 @default.
• W2927351594 cites W2068371994 @default.
• W2927351594 cites W2081270789 @default.
• W2927351594 cites W2083103008 @default.
• W2927351594 cites W2090673472 @default.
• W2927351594 cites W2090961207 @default.
• W2927351594 cites W2093657497 @default.
• W2927351594 cites W2103632818 @default.
• W2927351594 cites W2106282299 @default.
• W2927351594 cites W2109375582 @default.
• W2927351594 cites W2110706456 @default.
• W2927351594 cites W2112669742 @default.
• W2927351594 cites W2126812590 @default.
• W2927351594 cites W2155940319 @default.
• W2927351594 cites W2170766497 @default.
• W2927351594 cites W2171501803 @default.
• W2927351594 cites W2410589421 @default.
• W2927351594 cites W2474709579 @default.
• W2927351594 cites W2548045604 @default.
• W2927351594 cites W2560754340 @default.
• W2927351594 cites W2790355313 @default.
• W2927351594 cites W4248396965 @default.
• W2927351594 doi "https://doi.org/10.1590/0037-8682-0292-2018" @default.
• W2927351594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30942258" @default.
• W2927351594 hasPublicationYear "2019" @default.
• W2927351594 type Work @default.
• W2927351594 sameAs 2927351594 @default.
• W2927351594 citedByCount "12" @default.
• W2927351594 countsByYear W29273515942020 @default.
• W2927351594 countsByYear W29273515942021 @default.
• W2927351594 countsByYear W29273515942022 @default.
• W2927351594 countsByYear W29273515942023 @default.
• W2927351594 crossrefType "journal-article" @default.
• W2927351594 hasAuthorship W2927351594A5006447860 @default.
• W2927351594 hasAuthorship W2927351594A5012747514 @default.
• W2927351594 hasAuthorship W2927351594A5013224966 @default.
• W2927351594 hasAuthorship W2927351594A5022215664 @default.
• W2927351594 hasAuthorship W2927351594A5029601316 @default.
• W2927351594 hasAuthorship W2927351594A5032927791 @default.
• W2927351594 hasAuthorship W2927351594A5053182124 @default.
• W2927351594 hasAuthorship W2927351594A5057647506 @default.
• W2927351594 hasAuthorship W2927351594A5065033497 @default.
• W2927351594 hasAuthorship W2927351594A5070849509 @default.
• W2927351594 hasBestOaLocation W29273515941 @default.
• W2927351594 hasConcept C126322002 @default.
• W2927351594 hasConcept C141071460 @default.
• W2927351594 hasConcept C16005928 @default.
• W2927351594 hasConcept C168563851 @default.
• W2927351594 hasConcept C197934379 @default.
• W2927351594 hasConcept C203014093 @default.
• W2927351594 hasConcept C203092338 @default.
• W2927351594 hasConcept C2776555147 @default.
• W2927351594 hasConcept C2778689377 @default.
• W2927351594 hasConcept C2780423678 @default.
• W2927351594 hasConcept C2781413609 @default.
• W2927351594 hasConcept C2781417161 @default.
• W2927351594 hasConcept C44249647 @default.
• W2927351594 hasConcept C535046627 @default.
• W2927351594 hasConcept C71924100 @default.
• W2927351594 hasConcept C90924648 @default.
• W2927351594 hasConceptScore W2927351594C126322002 @default.
• W2927351594 hasConceptScore W2927351594C141071460 @default.
• W2927351594 hasConceptScore W2927351594C16005928 @default.
• W2927351594 hasConceptScore W2927351594C168563851 @default.
• W2927351594 hasConceptScore W2927351594C197934379 @default.

• next